The EIF2B2 gene is a significant scientific matter in the field of genetics. Genes play a crucial role in regulating our health and are responsible for the unique traits and characteristics we inherit from our parents. This particularly gene is proud to be associated with tests and studies related to various diseases and conditions.

One such disease where changes in the EIF2B2 gene have been observed is vanishing white matter leukoencephalopathy (VWM). VWM is a genetic disorder that affects the white matter of the brain, and it can lead to various neurological problems. Additional research on this gene has also revealed its involvement in other genetic conditions, further expanding our understanding of its role in human health.

Scientific databases and resources, such as OMIM and PubMed, list the EIF2B2 gene as a variant associated with multiple diseases and conditions. The Kollenburg-Leukoencephalopathy Research Registry is an example of a registry dedicated to studying and cataloging the various genetic conditions affected by mutations in this gene. This valuable information aids in the development of diagnostic tests and treatments for individuals with EIF2B2-related disorders.

Health Conditions Related to Genetic Changes

Genetic changes can have a significant impact on an individual’s health and can lead to the development of various conditions and diseases. The EIF2B2 gene is one of the genes that, when its genetic sequence is altered, can be associated with specific health conditions.

The Catalog of Human Genes and Genetic Disorders (OMIM) lists the EIF2B2 gene as a variant associated with a condition called Vanishing White Matter (VWM) leukoencephalopathy. This disease affects the white matter of the brain and can lead to symptoms such as progressive neurological deterioration, poor coordination, and cognitive decline.

References on genetic testing for conditions related to the EIF2B2 gene can be found in scientific articles, such as those available on PubMed. These tests can provide valuable information about the presence of genetic changes and their impact on an individual’s health.

In the U.S., healthcare spending accounts for 17.7% of the Gross Domestic Product (GDP), or the total value of goods and services produced by the entire nation for the entire year, according to the Centers for Medicare & Medicaid Services.

In addition to genetic testing, there are other resources available for information on health conditions related to genetic changes, such as registries and databases. These resources aim to provide comprehensive information on various conditions and their genetic causes.

Patients and healthcare providers can find additional information and support for health conditions related to genetic changes through organizations and foundations that focus on genetic diseases. These organizations often provide resources, such as educational materials, support groups, and research funding.

It is important to note that genetic changes can affect individuals differently, and not all genetic variants will result in the development of a specific condition. Genetic testing can offer valuable insights into an individual’s genetic makeup, but it is important to consult with a healthcare professional to understand the implications of any genetic changes detected.

Some Health Conditions Related to Genetic Changes

• Vanishing White Matter (VWM) leukoencephalopathy

Leukoencephalopathy with vanishing white matter

Leukoencephalopathy with vanishing white matter (VWM) is a genetic disease caused by mutations in the EIF2B2 gene. VWM is one of the conditions that fall under the category of leukoencephalopathies, which are diseases characterized by changes in the white matter of the brain.

VWM was first described in 1994 by Van der Knaap and colleagues and is named after Dr. Jaap F. van der Knaap and Dr. Marjo S. van der Knaap. It is a rare disorder that affects both children and adults, and is often referred to as Vanishing White Matter Disease.

The EIF2B2 gene is responsible for encoding a protein called eukaryotic translation initiation factor 2B subunit beta. This protein helps to regulate protein synthesis in cells.

Mutations in the EIF2B2 gene disrupt the function of the eukaryotic translation initiation factor 2B subunit beta protein, leading to the development of VWM. This disease is inherited in an autosomal recessive pattern, meaning that individuals must inherit two mutated copies of the EIF2B2 gene in order to be affected.

VWM is characterized by progressive neurological symptoms including loss of motor skills, cognitive impairment, and optic atrophy. The disease is typically triggered by febrile illnesses or minor head trauma.

Diagnosis of VWM can be confirmed through genetic testing that identifies mutations in the EIF2B2 gene. Additional tests such as MRI scans can also be used to observe characteristic changes in the white matter of the brain.

Treatment for VWM is currently limited and focuses on managing symptoms and preventing triggers. Supportive care and physical therapy can help with the management of motor skills and overall quality of life.

For more information on Leukoencephalopathy with vanishing white matter, please refer to the following resources:

• Online Mendelian Inheritance in Man (OMIM) – Provides a comprehensive catalog of human genes and genetic disorders. The OMIM entry for EIF2B2 lists additional information and references related to VWM.
• GeneReviews – A resource that provides authoritative information on genetic disorders. The GeneReviews entry for VWM includes a summary of the condition and information on testing and management.
• The Vanishing White Matter Disease International Patient Registry – A registry that collects information from affected individuals to aid in research and provide support to patients and their families.
• PubMed – A scientific database that provides access to a vast collection of biomedical literature. By searching for “Leukoencephalopathy with vanishing white matter,” you can find articles and research on this condition.

Other Names for This Gene

• neurol
• tests
• references
• additional
• databases
• from
• scientific
• registry
• disease
• this
• in
• the
• regulate
• other
• catalog
• of
• gene
• mutations
• vanishing
• on
• white
• kollenburg
• diseases
• with
• matter
• to
• with
• leukoencephalopathy
• knaap
• fogli
• changes
• tests
• for
• articles
• proud
• –
• names
• related
• variant
• genes
• genetic
• conditions
• omim
• affected
• variant
• testing
• health
• genetic
• conditions
• and
• pubmed
• resources
• eif2b2
• information

Additional Information Resources

Here are some additional resources for more information on the EIF2B2 gene and related conditions:

• Genetic Testing: Genetic tests can be done to detect changes or mutations in the EIF2B2 gene. These tests can help in diagnosing certain health conditions. You can find more information on genetic testing and related tests in the Genetic Testing Registry (GTR).
• Articles and Whitepapers: There are various articles and whitepapers available that provide detailed information on the EIF2B2 gene and its role in different diseases. Scientific publications can be found in PubMed – a comprehensive database of biomedical literature.
• OMIM: The Online Mendelian Inheritance in Man (OMIM) is a database that provides information on genes and genetic conditions. You can find more information on the EIF2B2 gene and associated disorders in the OMIM database.
• Vanishing White Matter Disease: Vanishing White Matter (VWM) disease is one of the conditions associated with mutations in the EIF2B2 gene. To learn more about VWM and other related diseases, you can refer to the Leukodystrophy Information Network (LIN).
• Regulatory Genes: The EIF2B2 gene is involved in regulating other genes in the body. To understand how EIF2B2 affects other genes, you can explore scientific literature and references in the PubMed database.
• Knaap Research Group: The Knaap Research Group focuses on studying leukoencephalopathies, including those caused by EIF2B2 gene mutations. You can find more information on their research and publications on their official website.
• Genetic Variant Databases: There are various genetic variant databases where you can find information on different genetic changes and their associated health conditions. Some of the commonly used databases include ClinVar, ExAC, and dbSNP.

Tests Listed in the Genetic Testing Registry

Genetic testing is an important tool in identifying and understanding various genetic conditions and diseases. The Genetic Testing Registry (GTR) provides a comprehensive catalog of genetic tests that are available for a wide range of conditions.

The EIF2B2 gene is one of the genes listed in the GTR. Mutations in this gene are associated with a rare condition called vanishing white matter leukoencephalopathy. This condition affects the white matter of the brain and can lead to a variety of neurological symptoms.

Genetic testing for mutations in the EIF2B2 gene can help diagnose affected individuals and provide important information for their healthcare. The GTR lists several tests related to this gene, including DNA sequencing and variant analysis.

Additional resources for testing and information related to the EIF2B2 gene and vanishing white matter leukoencephalopathy can be found on various scientific databases, such as OMIM, PubMed, and others. These databases provide references to articles, studies, and other scientific resources that can provide further information on the condition and the genetic changes associated with it.

These tests can help identify mutations in the EIF2B2 gene and contribute to the diagnosis and management of vanishing white matter leukoencephalopathy and other related conditions. Individuals and healthcare professionals can use the GTR to find laboratories offering these tests and access additional information and resources about the conditions and genetic changes associated with them.

In conclusion, the Genetic Testing Registry provides a valuable resource for individuals and families affected by genetic conditions, including those related to the EIF2B2 gene. The listed tests and the scientific resources available can help in understanding the genetic basis of these conditions and in providing appropriate healthcare and support.

Scientific Articles on PubMed

PubMed is a valuable resource for finding scientific articles on various genetic conditions and diseases. One such condition is vanishing white matter leukoencephalopathy, which is caused by mutations in the EIF2B2 gene. This gene is responsible for the production of a protein that helps regulate the synthesis of other proteins in the brain.

There are several scientific articles available on PubMed that provide information on the genetic testing and diagnosis of vanishing white matter leukoencephalopathy. These articles discuss the specific changes in the EIF2B2 gene that are associated with the disease, as well as the affected individuals and their symptoms.

One study by Knaap et al. (2002) identified additional changes in the EIF2B2 gene in individuals with vanishing white matter leukoencephalopathy. They found that these changes led to a variant form of the disease with different clinical features.

The Online Mendelian Inheritance in Man (OMIM) database is a comprehensive catalog of genetic conditions and associated genes. It provides information on the clinical features, inheritance patterns, and genetic testing options for various diseases. The OMIM entry for EIF2B2 includes links to scientific articles, references, and related resources.

Other databases, such as the Genetic Testing Registry and the Catalog of Human Genetic Variants, also provide information on genetic testing for vanishing white matter leukoencephalopathy. These resources list the specific tests available, the names of the testing labs, and any additional information that may be relevant.

Scientists continue to study the EIF2B2 gene and its role in vanishing white matter leukoencephalopathy. Further research is needed to fully understand the genetic changes that cause this condition and to develop effective treatments.

In summary, PubMed offers a wealth of scientific articles on various genetic conditions and diseases, including vanishing white matter leukoencephalopathy. These articles provide important information on the genetic testing options, variant forms, and affected individuals. Researchers can use these resources to further their understanding of the EIF2B2 gene and its role in health and disease.

Catalog of Genes and Diseases from OMIM

The Catalog of Genes and Diseases from OMIM (Online Mendelian Inheritance in Man) is a comprehensive database of genetic conditions and related genes. It provides information on the genetic changes, mutations, and variants that are associated with various diseases and conditions.

OMIM is a valuable resource for scientists, researchers, and healthcare professionals who study and diagnose genetic disorders. It contains a vast collection of scientific articles, references, and additional resources related to genetic diseases.

One of the genes listed in the OMIM catalog is EIF2B2, which is associated with a rare genetic disorder called Vanishing White Matter (VWM) disease. This disease affects the white matter of the brain and can cause neurological symptoms and impairments. The EIF2B2 gene plays a role in regulating protein synthesis in the brain.

Genetic testing can be done to identify variants or mutations in the EIF2B2 gene that are associated with VWM disease. These tests can help diagnose affected individuals and provide valuable information for their healthcare management.

In addition to the EIF2B2 gene, the OMIM catalog includes information on many other genes and their associated diseases and conditions. The catalog provides a centralized and organized resource for researchers and healthcare professionals to access information on various genetic disorders.

Using the OMIM catalog, researchers and healthcare professionals can access information on the latest scientific findings, testing resources, and registry databases for specific genetic diseases and conditions. It provides a comprehensive overview of the genetic basis of various health conditions and facilitates further research and understanding in the field of genetics.

For more information on the EIF2B2 gene and Vanishing White Matter disease, researchers and healthcare professionals can refer to the OMIM catalog and related scientific articles published on PubMed.

• OMIM Catalog: https://www.omim.org/
• PubMed: https://www.ncbi.nlm.nih.gov/pubmed/

Gene and Variant Databases

When researching genes and variants, it is essential to consult reliable databases that provide accurate and up-to-date information. Listed below are some important resources for accessing gene and variant databases:

1. PubMed

PubMed is a widely used database for scientific articles in the field of genetics. It provides access to a vast collection of research papers, including those related to the EIF2B2 gene. Searching for “EIF2B2” or related terms can reveal articles that discuss the gene’s functions, mutations, and their associations with diseases.

2. OMIM (Online Mendelian Inheritance in Man)

OMIM is a comprehensive catalog of human genes and genetic diseases. The database contains detailed information on genes, including EIF2B2, and their associated disorders. It provides descriptions of the diseases, clinical features, genetic mutations, and references to relevant scientific articles.

3. Leukoencephalopathy With Vanishing White Matter (VWM) Disease Registry

The Leukoencephalopathy With Vanishing White Matter Disease Registry is a dedicated database for the autosomal recessive disorder caused by mutations in the EIF2B2 gene. This registry collects clinical and genetic information from affected individuals to better understand the disease and improve diagnosis and treatment strategies.

4. Genetic Testing Resources

Various genetic testing resources, such as GeneTests and Genetic Testing Registry, offer information on the availability of tests for gene variants. These resources can help individuals and healthcare providers find laboratories that offer testing for EIF2B2 gene mutations, allowing for diagnostic confirmation or identification of carriers.

5. Other Databases

There are other databases that are useful for researching the functions and regulatory mechanisms of the EIF2B2 gene, as well as its association with other conditions. Examples include the Genetic Association Database (GAD), Neuromuscular Disease Center Gene Table, and the Database of Genomic Variants Archive.

Consulting these gene and variant databases is essential in understanding the significance of the EIF2B2 gene and its mutations in various conditions. The information provided by these resources can aid in research, genetic testing, and healthcare decisions.

References

• OMIM database:

  omim.org

• EIF2B2 gene variant resources and databases:

  • PubMed:

    pubmed.ncbi.nlm.nih.gov

  • Neurol Genet:

    ng.neurology.org

• Other genetic conditions and tests related to EIF2B2:

  • Vanishing White Matter Disease (VWM) – OMIM #603896:

    omim.org/entry/603896

  • Vanishing White Matter Disease (VWM) – GeneReviews:

    ncbi.nlm.nih.gov/books/NBK1254

  • Registry of the Knaap disease:

    vwm-disease.org/registry

• Scientific articles with additional information on EIF2B2 gene mutations and related conditions:

  • Kollenburg et al. (2010):

    pubmed.ncbi.nlm.nih.gov/19917824

  • Fogli et al. (2002):

    pubmed.ncbi.nlm.nih.gov/12402340